These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24120587)

  • 1. The results of nucleic acid testing in remunerated and non-remunerated blood donors in Lithuania.
    Kalibatas V; Kalibatienė L
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s58-62. PubMed ID: 24120587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payment for whole blood donations in Lithuania: the risk for infectious disease markers.
    Kalibatas V
    Vox Sang; 2008 Apr; 94(3):209-215. PubMed ID: 18069929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of nucleic acid testing for viruses in individual donor test and its importance for the safety of blood].
    Kalibatas V
    Medicina (Kaunas); 2008; 44(10):791-8. PubMed ID: 19001837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the risk of transfusion-transmitted infectious disease markers in blood and blood component donations: Movement from remunerated to voluntary, non-remunerated donations in Lithuania from 2013 to 2020.
    Kalibatas V; Kalibatienė L
    PLoS One; 2022; 17(11):e0277650. PubMed ID: 36378657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing blood transfusion safety using molecular detection in the country of Georgia.
    Alkhazashvili M; Bloch EM; Shadaker S; Kuchuloria T; Getia V; Turdziladze A; Armstrong PA; Gamkrelidze A
    Transfus Clin Biol; 2023 Aug; 30(3):307-313. PubMed ID: 36907246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priority needs and wisdom strategy for blood transfusion safety in developing low-resource countries.
    Abdelrazik AM; Ezzat Ahmed GM
    Transfus Apher Sci; 2016 Feb; 54(1):147-9. PubMed ID: 26874467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
    Whyte GS; Savoia HF
    Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT positivity in seronegative voluntary blood donors from western India.
    Mishra KK; Trivedi A; Sosa S; Patel K; Ghosh K
    Transfus Apher Sci; 2017 Apr; 56(2):175-178. PubMed ID: 28041821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
    Ben Jemia R; Gouider E
    Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
    Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
    J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
    Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
    Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.